health canada bpc-157 Public advisory BPC-157 – Montreal Peptides Canada

FilipRGheorghita PuscaseluRAnchidin-NorocelLDimianMSavageWK

Lakhal, S

Storage Protocol Store lyophilized peptide at -20C in original packaging Reconstitute only the amount needed for current research phase Refrigerate reconstituted peptide at 2-8C Use within 4 weeks of reconstitution for BAC water preparations Document reconstitution date and concentration on vial Handling Practices Minimize Freeze-Thaw: Aliquot into single-use portions if freezing is necessary Aseptic Technique: Treat all reconstituted peptide as sterile

Skin Wound Healing Some experiments also showed that BPC-157 could accelerate wound healing on the skin, indicating that its benefits might not be limited to internal tissues alone

It is tempting to speculate that the tethering of the N-terminal segment to the stalk region may stabilize c-MET in a specific extended conformation, which might be important for the efficient activation of c-MET

Cardiometabolic Risk Reduction Clinical Trials: Cagrilintide is currently in Phase 3 clinical development